4Schwartz etal.A syndrome of renal sodium loss and hypon-atremia probably resulting from inappropriate secretion of antidiuretic hormone[J].American Journal of Medicine,1957,23(4):529.
2Eckardt JR,von Pawel J,Pujol JL,et al.Phase Ⅲ study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer[J].J Clin Oncol,2007,25(22):2086-2092.
3O'Brien ME,Ciuleanu TE,Tsekov H,et al.Phase Ⅲ trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer[J].J Clin Oncol,2006,24(34):5441-5447.
4Inoue A,Sugawara S,Yamazaki K,et al.Randomized phase Ⅱ trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer:North Japan Lung Cancer Study Group Trial 0402[J].J Clin Oncol,2008,26(33):5401-5406.
5Onoda S,Masuda N,Seto T,et al.Phase Ⅱ trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer:Thoracic Oncology Research Group Study 0301[J].J Clin Oncol,2006,24(34):5448-5453.
6Treat J,Schiller J,Quoix E,et al.ZD0473 treatment in lung cancer:an overview of the clinical trial results[J].Eur J Cancer,2002,38(8 Suppl):13-18.
7Ciuleanu T,Samarzjia M,Demidchik Y,et al.Randomized phase Ⅲ study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy[J].J Clin Oncol,2010,28(15 Suppl):a7002.
8Fossella FV,Tolcher A,Elliott M,et al.Phase Ⅰ trial of the monoclonal antibody conjugate,BB-10901,for relapsed/refractory small cell lung cancer (SCLC) and other neuroendocrine (NE) tumors[J].Proc Am Soc Clin Oncol,2002,21:a1232.
9McCann J,Fossella FV,Villalona-Calero MA,et al.Phase Ⅱ trial of huN901-DM1 in patients with relapsed small cell lung cancer (SCLC) and CD56-positive small cell carcinoma[J].J Clin Oncol,2007,25 (Suppl 18):a690.
10Fossella FV,McCann J,Tolcher A,et al.Phase Ⅱ trial of BB-10901 (huN901-DM1) given weekly for four consecutive weeks every 6 weeks in patients with relapsed SCLC and CD56-positive small cell carcinoma[J].J Clin Oncol,2005,23 (Suppl 16):a660.
5Olfred Hansen,Peter Soensen,et al.The occurrence of hyponatremia in SCLC and the influence on prognosis:A retrospective study of 453 patients treated in a single institution in a 10-year period[J].Lung Cancer,2010,68(1):111.
6Hansen H.Textbook of lung cancer[M].2nd Ed.Copenhagen:Informa Health Care,2008:82-83.
7Tai P,Yu E,Jones K,et al.Syndrom of inaoomprate antidiuretic homone secretion(SIADH)in patients with liIIlited stage small cell lung cancer[J].Lung Cancer,2006,53(2):211.